Analysts: Walgreens Shows Long-Term Prospects and 3 Other Research Notes to Peruse

Walgreens (NYSE:WAG): Morgan Stanley upgraded Walgreens to Overweight from Equal Weight. The firm upgraded shares based on 2016 fiscal year growth prospects when the Alliance Boots deal is completed, deal synergies, and coverage expansion. The shares’ price target is $70.